It has become increasingly clear that inflammatory bowel disease (IBD) develops on the background of genetic defects in the host, conveying an increased susceptibility to an environmental antigen or antigens. The environmental factor implicated in the pathophysiology of gut inflammation, which is un
Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients
✍ Scribed by Andrzej Szkaradkiewicz; Ryszard Marciniak; Izabela Chudzicka-Strugała; Agnieszka Wasilewska; Michał Drews; Przemysław Majewski; Tomasz Karpiński; Barbara Zwoździak
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 158 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0004-069X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Ulcerative colitis and Crohn's disease both confer an increased risk of developing colorectal cancer. The use of 5-aminosalicylate as a remission-inducing agent has been long accepted. Its use as a potential chemoprophylactic agent has been proposed and is used by some practitioners. This review exa
## Background: The histological variability in colitis-associated colorectal cancer (crc in inflammatory bowel disease [ibd]) and the association to clinical factors is unknown. ## Methods: In population-based material including 67 patients with crc in ibd, histopathology of the cancers and tissu